You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / NEULAND LABORATORIES

NEULAND LABORATORIES
Intrinsic Value | Fundamental Analysis

Returns | 1W : 10.5% , 1M : 33.7%,1Y : 563%
BOM : 524558     NSE : NEULANDLAB    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Apr 22,2021
Price(EOD): Rs. 2,661.65
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 3,406.91 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
NEULAND LABORATORIES 10.5% 33.7% 563%
SUN PHARMACEUTICAL INDUSTRIES 1.2% 11.4% 36.3%
DR REDDYS LABORATORIES 7.4% 23.5% 34.1%
DIVIS LABORATORIES -0.8% 14.8% 61.7%
CIPLA 3.3% 25.1% 62.3%
BIOCON -1.2% 2.6% 12.1%
AUROBINDO PHARMA 8.6% 23.1% 82.7%
LUPIN 1.1% 6.1% 34.7%
TORRENT PHARMACEUTICALS 0.4% 8.8% 11.6%

FUNDAMENTAL ANALYSIS OF NEULAND LABORATORIES

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than NEULAND LABORATORIES Premium


VALUATION OF NEULAND LABORATORIES

 
Valuation Score
RatioValue
P/E
P/B
P/S
215
P/E Calculated based on EPS of 12.38
[ Mar2020 - Standalone Results ]

4.85
P/B Calculated based on Book Value of 549.21
[ Mar2020 - Standalone Results ]

4.33
P/S Calculated based on Revenues of 787.128 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than NEULAND LABORATORIES Premium


FAIR VALUE OF NEULAND LABORATORIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
326%
234%
264%

SHARE PRICE MOMENTUM OF NEULAND LABORATORIES

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.37
0.33
1.31
0.67
0.37
0.33
1.3
0.67
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
4.3 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
1.66%
12.91%
11.45%
24.99%
20.51%
60.59%
104.55%
141.54%
QtrlyTrend
8
Latest Qtr: Dec2020

NEULAND LABORATORIES related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 3.7% 15.3% 56.9%
S&P BSE SMALL CAP 0.5% 2.5% 90.8%
S&P BSE MIDSMALLCAP 0.2% 1.7% 80%
S&P BSE ALLCAP -0.8% -0.3% 59.7%
No NSE index found

FAQ [Frequently Asked Questions]


Is NEULANDLAB good for long term investment?

As on 22-Apr-2021, the Fundamentals of NEULANDLAB are Average and hence you can wait for the results to improve to invest for long term ! See Financial Performance of NEULAND LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is NEULANDLAB UnderValued or OverValued?

As on 22-Apr-2021, NEULANDLAB is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of NEULANDLAB ?

As on 22-Apr-2021, the Intrinsic Value of NEULANDLAB is Rs. 731.78 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 624.97
Fair Value [Median EV / Sales Model] : Rs. 796.08
Fair Value [Median Price / Sales Model] : Rs. 731.78
Median Fair Value of NEULANDLAB : Rs. 731.78

Is NEULANDLAB trading at a Premium or Discount?

As on 22-Apr-2021, NEULANDLAB is trading at a Premium of 264% based on the Median Intrinsic Value!

Is it right time to buy NEULANDLAB shares?

As on 22-Apr-2021, NEULANDLAB is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of NEULANDLAB?

Check out Financials of Industry Peers using below links:
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD

What are the Frequent Comparisons with NEULANDLAB?

NEULAND LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
NEULAND LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
NEULAND LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
NEULAND LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
NEULAND LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
NEULAND LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
NEULAND LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
NEULAND LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
NEULAND LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z